Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 21,150
+150 (0.71%)
Apr 10, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 949.38 billion as of April 10, 2026. Its market cap has increased by 528.10% in one year.
Market Cap
949.38B
Enterprise Value
896.77B
Revenue
53.39B
Ranking
n/a
PE Ratio
60.15
Stock Price
21,150.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 949.38B, an increase of 407.94%. That is a compound annual growth rate of 247.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 942.64B | 8.38% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.63T |
| Chabiotech | 1.58T |
| Pharmicell | 873.66B |
| GI Innovation | 779.96B |
| MEDIPOST | 766.47B |
| Proteina | 645.43B |
| Medy-Tox | 639.79B |
| Green Cross Holdings | 608.84B |